Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Neuro-Oncology Advances|June 29, 2026
Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastomaMariangela Morelli, Francesca Di Lorenzo, Francesca Marchetto, et al.European Journal of Endocrinology|September 16, 2022
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort studyMirela Diana Ilie, Chiara Villa, Thomas Cuny, et al.Journal of Neuro-Oncology|December 10, 2014
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumabAnna Luisa Di Stefano, Marianne Labussiere, Giuseppe Lombardi, et al.Cell Death Discovery|April 13, 2026
BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerabilitySara Franceschi, Mariangela Morelli, Francesca Lessi, et al.Neurology|September 30, 2022
In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas: The IDASPE Prospective StudyAnna Luisa Di Stefano, Lucia Nichelli, Giulia Berzero, et al.Nature Cancer|March 8, 2021
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesLuciano Garofano, Simona Migliozzi, Young Taek Oh, et al.Frontiers in Genetics|October 24, 2012
Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approachDaniel I Jacobs, Kyle M Walsh, Margaret Wrensch, et al.Neuro-Oncology Advances|May 30, 2024
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive gliomaAlberto Picca, Anna Luisa Di Stefano, Julien Savatovsky, et al.Nature Communications|February 14, 2025
Learning and actioning general principles of cancer cell drug sensitivityFrancesco Carli, Pierluigi Di Chiaro, Mariangela Morelli, et al.Neuro-Oncology|May 16, 2020
Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusionsAnna Luisa Di Stefano, Alberto Picca, Edouard Saragoussi, et al.Pageof 9